140
Participants
Start Date
September 30, 2005
Primary Completion Date
February 29, 2016
Study Completion Date
November 30, 2017
Teriparatide
Teriparatide will be given subcutaneously in 20-mcg doses either continuously or cyclically.
Alendronate
Participants will take 70 mg per week of alendronate for 48 months.
Calcium
Calcium supplements will be administered in varied amounts for all participants, but each participant will take enough to bring her total daily calcium intake to 1,200 mg.
Vitamin D3
Vitamin D3 supplements will be administered in varied amounts for all participants, but each participant will take enough to bring her total daily intake to 1,200 mg.
Helen Hayes Hospital, West Haverstraw
Collaborators (1)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Health Research, Inc.
OTHER
Helen Hayes Hospital
OTHER